KNIGHT THERAPEUTICS INC (GUD.CA) Stock Income Statement
TSX:GUD - CA4990531069 - Common Stock
6.44 CAD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 384.56M | 371.30M | 328.20M | 293.56M | 243.48M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Cost Of Goods | 219.50M | 196.90M | 175.55M | 155.50M | 128.07M | |||
| Gross Profit | 165.07M | 174.41M | 152.65M | 138.06M | 115.41M | |||
| Operating Expenses | 174.03M | 167.01M | 146.28M | 155.12M | 128.24M | |||
| Research and Development | 23.59M | 23.30M | 17.55M | 14.76M | 12.69M | |||
| Selling, General, and Administrative Expenses | 108.43M | 99.35M | 83.69M | 88.62M | 74.38M | |||
| Operating Income | -8.96M | 7.40M | 6.37M | -17.06M | -12.83M | |||
| Interest Income/Expense | -38.00K | -16.23M | -28.50M | -15.76M | 14.04M | |||
| Other Income/Expense | 1.48M | 10.89M | 6.10M | 10.59M | 5.06M | |||
| Non Recurring Items | N/A | 0.00 | -5.96M | -21.72M | 423.00K | |||
| Income Before Taxes | -7.53M | 2.05M | -21.99M | -43.96M | 6.69M | |||
| Income Tax | -7.91M | -2.28M | -5.15M | -14.07M | -8.98M | |||
| Net Income | 383.00K | 4.33M | -16.84M | -29.89M | 15.68M | |||
| EBITDA | 42.12M | 60.51M | 56.77M | 45.56M | 35.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.00 | 0.04 | -0.16 | -0.26 | 0.13 | |||
| Non GAAP EPS | 0.00 | 0.05 | -0.16 | -0.26 | 0.12 | |||
| Statistics | ||||||||
| Gross Profit Margin | 42.92% | 46.97% | 46.51% | 47.03% | 47.40% | |||
| Profit Margin | 0.10% | 1.17% | -5.13% | -10.18% | 6.44% | |||
| Operating Profit Margin | -2.33% | 1.99% | 1.94% | -5.81% | -5.27% | |||
All data in CAD